• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.09% Nasdaq Up0.98%

    Opexa Therapeutics, Inc. (OPXA)

    -NasdaqCM
    0.42 Up 0.01(2.47%) 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 377   308   308   308  
    Cost of Revenue -   -   -   -  
    Gross Profit 377   308   308   308  
    Operating Expenses
    Research Development2,637  2,725  3,174  3,409  
    Selling General and Administrative1,006  846  917  967  
    Non Recurring -   -   -   -  
    Others97  96  97  99  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (3,363) (3,359) (3,881) (4,168)
    Income from Continuing Operations
    Total Other Income/Expenses Net12  5  3  4  
    Earnings Before Interest And Taxes(3,351)(3,354)(3,877)(4,163)
    Interest Expense -  1  1   -  
    Income Before Tax(3,351)(3,355)(3,878)(4,163)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(3,351)(3,355)(3,878)(4,163)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (3,351) (3,355) (3,878) (4,163)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (3,351) (3,355) (3,878) (4,163)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.